// App-Quantinova.ai

: A Novel and Potent Inhibitor of E-Selectin, GMI-1687, Attenuates Thrombus Formation and Augments Chemotherapeutic Intervention of AML in Preclinical Models Following Subcutaneous Administration

Researchers

Presenter

  • John Peterson

Principal Investigators

  • Myung-Gi Baek

  • Silvia Locatelli-Hoops

  • Ji-Won Lee

  • Lingquan Deng

  • David A Stewart

  • Theodore AG Smith

  • Daniel Durant Myers

  • William E Fogler

  • John L Magnani

Medical Centers

  • GlycoMimetics Inc, Rockville, MD.

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Acute myelocytic leukemia

  • Venous thrombosis

Biomarkers

  • E-selectin

Drug/Treatment

  • Daunorubicin

  • GMI1271

  • Cytarabine liposomal

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved